CPS
  • Home

Sign in or register to track your progress, save, and view your completed history.

Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Urothelial Carcinoma, Lung Cancer​

The Development of a CDx IHC Assay

    clockimg 3m
  • Tutorial
  • Foundational
 saveimgSave unsaveimgUnsave

 

In this foundational PD-L1 IHC 22C3 pharmDx Tutorial Video, you will learn:​

  • The purpose and advantages of a CDx Assay​
  • How CDx assay development fits into the drug development pathway​

 

Agilent’s PD-L1 IHC 22C3 pharmDx tutorial videos are an engaging and convenient resource for advancing your knowledge of PD-L1 interpretation using Tumor Proportion Score (TPS) and Combined Positive Score (CPS). Through these trainings we will help you to confidently:​

  • Understand the fundamentals of TPS and CPS including key inclusion and exclusion criteria for evaluation​
  • Navigate challenging morphology and staining characteristics​
  • Apply helpful strategies to confidently determine PD-L1 expression levels using TPS and CPS​

Related Training

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.​D0113779_1.00